CUMYL-BC-HPMEGACLONE-221

Cumyl-BC-HpMeGaClone-221 (Cumyl-NBMeGaClone^[1], Cumyl-BC[2.2.1]HpMeGaClone, SGT-271) is a gamma-carboline derivative which is a synthetic cannabinoid that has been sold as a designer drug.^[2] It was first identified in Germany in September 2020.^[3]

Cumyl-BC-HpMeGaClone-221

Legal status
Legal status	CA: Schedule II DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act
Identifiers
IUPAC name 5-({Bicyclo[2.2.1]heptan-2-yl}methyl)-2-(2-phenylpropan-2-yl)-1H,2H,5H-pyrido[4,3-b]indol-1-one
PubChem CID	163190698
ChemSpider	115285286
CompTox Dashboard (EPA)	DTXSID501336924
Chemical and physical data
Formula	C28H30N2O
Molar mass	410.561 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC(C)(c1ccccc1)N1C=Cc2n(CC3CC4CCC3C4)c3ccccc3c2C1=O
InChI InChI=1S/C28H30N2O/c1-28(2,22-8-4-3-5-9-22)30-15-14-25-26(27(30)31)23-10-6-7-11-24(23)29(25)18-21-17-19-12-13-20(21)16-19/h3-11,14-15,19-21H,12-13,16-18H2,1-2H3 Key:VFBNNQOHBYEVLU-UHFFFAOYSA-N

See also

• CUMYL-CB-MEGACLONE
• CUMYL-CH-MEGACLONE
• CUMYL-PEGACLONE
• CUMYL-NBMINACA